Asia Pacific Breast Reconstruction Market
Breast reconstruction is the surgical method of reconstructing the shape and looks of a breast, most generally in women who have had surgery to treat breast cancer. It includes autologous tissue, prosthetic implants, or a mixture of both, to reconstruct a natural-looking breast. Breast reconstruction techniques have developed over the last numerous decades, with options tailored to the individual needs of women with breast cancer.
Thus, the high prevalence of breast cancer is expected to create a significant demand for breast reconstruction in the coming years, which is further anticipated to drive the breast reconstruction market.
Asia Pacific countries are expecting to witness huge challenge due to growing COVID-19. Due to outbreak of disease, healthcare industries have been affected badly, considering the economic conditions in current situation. Due to growing coronavirus cases, many seminars and international conference has been postponed. For instance, 9th Asia Pacific Breast Cancer Summit has been postponed after 13th to 15th march due to current growing coronavirus. Restrictive measures have been taken to control the spread of this pandemic, however, in this measure’s cancer patients are not being treated on priority. For instance, according to Japanese report of 2020, “more than half of breast surgeries and breast reconstructions had to be postponed during the COVID-19 pandemic, and the number of candidates for surgery was also lower compared to the pre-pandemic periods. Triage of patients with breast cancer did not result in any adverse oncological outcomes for these patients. COVID-19 has had a major impact on breast cancer surgery and breast reconstruction, and there was substantial postponement of surgery. Apart from overall health system, cancer care delivery system has been facing challenges due to coronavirus outbreak.
Strategic insights for the Asia Pacific Breast Reconstruction provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 117.7 Million |
| Market Size by 2028 | US$ 184.9 Million |
| Global CAGR (2021 - 2028) | 6.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | Asia-Pacific
|
| Market leaders and key company profiles |
The geographic scope of the Asia Pacific Breast Reconstruction refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Breast reconstruction market in Asia Pacific is expected to grow from US$ 117.7 million in 2021 to US$ 184.9 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028. Breast cancer is one of the most common types of cancer observed among women. It is majorly characterized by the development of lumps in breasts, inversion of nipples, change in breast shape, release of fluids from nipples, red or scaly patches on skin, dimpling of the skin, and pain and soaring of nipples. Breast cancer is treated using mastectomy, a procedure that includes removal of entire breast through a surgical process. Breast reconstruction surgeries are used to rebuild the breasts after mastectomy. Implant reconstruction and autologous or flap reconstruction are the two main techniques used in these surgeries. With the increasing prevalence of breast cancer worldwide, many women are opting for reconstruction procedures to regain the original shape of their breasts after the mastectomy. According to breastcancer.org, as of January 2018, over 3.1 million women in the US had a history of breast cancer, including those who were undergoing a treatment and those who had undergone treatments in the past. Further, according to a study published by the World Health Organization (WHO), ~2.3 million women across the world were newly diagnosed with breast cancer in 2020. In addition, according to a study published in the journal of American Society of Clinical Oncology in 2020, ~1 in 29 women in India suffers from breast cancer at some point in life. The increasing prevalence of breast cancer, coupled with the growing preference for breast reconstruction procedures post mastectomy, is expected bolstering the market growth.
In terms of technology, the inframammary segment accounted for the largest share of the Asia Pacific breast reconstruction market in 2020. In terms of type, the breast implants segment accounted for the largest share of the Asia Pacific breast reconstruction market in 2020. In terms of placement, the dual plane insertion segment accounted for the largest share of the Asia Pacific breast reconstruction market in 2020. In terms of procedure, the immediate procedures segment held a larger market share of the breast reconstruction market in 2020.
A few major primary and secondary sources referred to for preparing this report on the breast reconstruction market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc
By Technology
By Type
By Placement
By Procedure
By Country
The Asia Pacific Breast Reconstruction Market is valued at US$ 117.7 Million in 2021, it is projected to reach US$ 184.9 Million by 2028.
As per our report Asia Pacific Breast Reconstruction Market, the market size is valued at US$ 117.7 Million in 2021, projecting it to reach US$ 184.9 Million by 2028. This translates to a CAGR of approximately 6.7% during the forecast period.
The Asia Pacific Breast Reconstruction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Breast Reconstruction Market report:
The Asia Pacific Breast Reconstruction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Breast Reconstruction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Breast Reconstruction Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Breast Reconstruction Market
